Pauwels Eric, Chief Business Officer at PTC Therapeutics ($PTCT), sold over 8.8 million dollars worth of company shares on the open market 38 times in the last year. His most recent sale occurred on February 18, 2026. These sales rank him 1,242nd among 11,678 insiders by total value sold, compared to an average of about 8.6 million dollars per insider across roughly 6 transactions. Eric Pauwels made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 3019 | $69.36 | 77,122.0000 | 88,311,494 | 3.77% | 0.00% |
| Jan. 8, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 587 | $76.98 | 84,341.0000 | 88,311,494 | 0.69% | 0.00% |
| Jan. 8, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1454 | $76.45 | 82,887.0000 | 88,311,494 | 1.72% | 0.00% |
| Jan. 9, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1722 | $77.41 | 81,165.0000 | 88,311,494 | 2.08% | 0.00% |
| Jan. 12, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1024 | $78.70 | 80,141.0000 | 88,311,494 | 1.26% | 0.00% |
| Jan. 8, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 2561 | $76.42 | 84,928.0000 | 88,311,494 | 2.93% | 0.00% |
| Jan. 6, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1789 | $76.95 | 88,841.0000 | 88,311,494 | 1.97% | 0.00% |
| Jan. 7, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1352 | $77.48 | 87,489.0000 | 88,311,494 | 1.52% | 0.00% |
| Jan. 2, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | A | Common Stock | 20000 | $0.00 | 90,630.0000 | 88,311,494 | 28.32% | 0.02% |
| Jan. 2, 2026 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 88,311,494 | 9999.99% | 0.06% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 59 | $78.01 | 70,373.0000 | 87,115,369 | 0.08% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 37 | $75.66 | 70,474.0000 | 87,115,369 | 0.05% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 138 | $66.49 | 70,511.0000 | 87,115,369 | 0.20% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 19805 | $0.00 | 0.0000 | 87,115,369 | 100.00% | 0.02% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 565 | $0.00 | 17,566.0000 | 87,115,369 | 3.12% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 138 | $0.00 | 19,805.0000 | 87,115,369 | 0.69% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 3220 | $78.33 | 70,373.0000 | 87,115,369 | 4.38% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 10548 | $77.55 | 73,593.0000 | 87,115,369 | 12.54% | 0.01% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 4537 | $76.33 | 84,141.0000 | 87,115,369 | 5.12% | 0.01% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1500 | $75.77 | 88,678.0000 | 87,115,369 | 1.66% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 19805 | $66.49 | 90,178.0000 | 87,115,369 | 28.14% | 0.02% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 59 | $78.43 | 70,373.0000 | 87,115,369 | 0.08% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 313 | $77.73 | 70,432.0000 | 87,115,369 | 0.44% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 193 | $75.45 | 70,745.0000 | 87,115,369 | 0.27% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 565 | $18.01 | 70,938.0000 | 87,115,369 | 0.80% | 0.00% |
| Dec. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 42 | $77.26 | 70,432.0000 | 87,115,369 | 0.06% | 0.00% |
| Dec. 18, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 2831 | $75.07 | 70,373.0000 | 87,115,369 | 3.87% | 0.00% |
| Dec. 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 36606 | $0.00 | 22,894.0000 | 87,115,369 | 61.52% | 0.04% |
| Dec. 18, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 2951 | $0.00 | 19,943.0000 | 87,115,369 | 12.89% | 0.00% |
| Dec. 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 3684 | $0.00 | 18,382.0000 | 87,115,369 | 16.70% | 0.00% |
| Dec. 18, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 251 | $0.00 | 18,131.0000 | 87,115,369 | 1.37% | 0.00% |
| Dec. 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 100 | $76.00 | 70,373.0000 | 87,115,369 | 0.14% | 0.00% |
| Dec. 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 35361 | $66.49 | 105,734.0000 | 87,115,369 | 50.25% | 0.04% |
| Dec. 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 35261 | $75.44 | 70,473.0000 | 87,115,369 | 33.35% | 0.04% |
| Dec. 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 100 | $76.00 | 70,373.0000 | 87,115,369 | 0.14% | 0.00% |
| Dec. 18, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 120 | $66.49 | 70,493.0000 | 87,115,369 | 0.17% | 0.00% |
| Dec. 18, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 120 | $75.02 | 70,373.0000 | 87,115,369 | 0.17% | 0.00% |
| Dec. 18, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 251 | $18.01 | 70,624.0000 | 87,115,369 | 0.36% | 0.00% |
| Dec. 18, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 251 | $75.00 | 70,373.0000 | 87,115,369 | 0.36% | 0.00% |
| Dec. 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 3584 | $75.31 | 70,473.0000 | 87,115,369 | 4.84% | 0.00% |
| Dec. 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 3684 | $18.01 | 74,157.0000 | 87,115,369 | 5.23% | 0.00% |
| Dec. 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1245 | $75.28 | 72,912.0000 | 87,115,369 | 1.68% | 0.00% |
| Dec. 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 1245 | $66.49 | 74,157.0000 | 87,115,369 | 1.71% | 0.00% |
| Dec. 18, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 2831 | $66.49 | 73,204.0000 | 87,115,369 | 4.02% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 2406 | $0.00 | 0.0000 | 78,151,240 | 100.00% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 2406 | $56.92 | 72,912.0000 | 78,151,240 | 3.19% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 16698 | $30.86 | 89,610.0000 | 78,151,240 | 22.90% | 0.02% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 16698 | $56.94 | 72,912.0000 | 78,151,240 | 18.63% | 0.02% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 6017 | $11.23 | 78,929.0000 | 78,151,240 | 8.25% | 0.01% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 6017 | $56.91 | 72,912.0000 | 78,151,240 | 7.62% | 0.01% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 8528 | $18.01 | 81,440.0000 | 78,151,240 | 11.70% | 0.01% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 8528 | $56.92 | 72,912.0000 | 78,151,240 | 10.47% | 0.01% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 3713 | $30.86 | 76,625.0000 | 78,151,240 | 5.09% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 3713 | $56.92 | 72,912.0000 | 78,151,240 | 4.85% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 2406 | $11.23 | 75,318.0000 | 78,151,240 | 3.30% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 1238 | $11.32 | 74,150.0000 | 78,151,240 | 1.70% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1238 | $56.85 | 72,912.0000 | 78,151,240 | 1.67% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Common Stock | 1250 | $11.32 | 74,162.0000 | 78,151,240 | 1.71% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1250 | $56.86 | 72,912.0000 | 78,151,240 | 1.69% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 16698 | $0.00 | 3,713.0000 | 78,151,240 | 81.81% | 0.02% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 6017 | $0.00 | 2,406.0000 | 78,151,240 | 71.44% | 0.01% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 8528 | $0.00 | 0.0000 | 78,151,240 | 100.00% | 0.01% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 3713 | $0.00 | 0.0000 | 78,151,240 | 100.00% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 1238 | $0.00 | 1,250.0000 | 78,151,240 | 49.76% | 0.00% |
| Sept. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | M | Stock Option (Right to Buy) | 1250 | $0.00 | 0.0000 | 78,151,240 | 100.00% | 0.00% |
| March 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 2037 | $55.24 | 77,365.0000 | 76,845,055 | 2.57% | 0.00% |
| March 14, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 4458 | $55.19 | 79,402.0000 | 76,845,055 | 5.32% | 0.01% |
| March 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1085 | $56.62 | 76,280.0000 | 76,845,055 | 1.40% | 0.00% |
| March 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 3340 | $57.67 | 72,940.0000 | 76,845,055 | 4.38% | 0.00% |
| March 17, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 300 | $58.31 | 72,640.0000 | 76,845,055 | 0.41% | 0.00% |
| Feb. 19, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1378 | $50.10 | 85,427.0000 | 76,845,055 | 1.59% | 0.00% |
| Feb. 20, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1567 | $50.12 | 83,860.0000 | 76,845,055 | 1.83% | 0.00% |
| Jan. 8, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF EXECUTIVE OFFICER | S | Common Stock | 2136 | $44.50 | 86,805.0000 | 76,845,055 | 2.40% | 0.00% |
| Jan. 7, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1599 | $45.34 | 88,941.0000 | 76,845,055 | 1.77% | 0.00% |
| Jan. 3, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF EXECUTIVE OFFICER | A | Common Stock | 22000 | $0.00 | 90,540.0000 | 76,845,055 | 32.10% | 0.03% |
| Jan. 3, 2025 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 76,845,055 | 9999.99% | 0.07% |
| April 17, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF EXECUTIVE OFFICER | S | Common Stock | 787 | $25.14 | 67,694.0000 | 76,496,127 | 1.15% | 0.00% |
| Feb. 15, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | A | Common Stock | 22000 | $0.00 | 66,181.0000 | 74,838,292 | 49.80% | 0.03% |
| Feb. 15, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | A | Common Stock | 2300 | $0.00 | 68,481.0000 | 74,838,292 | 3.48% | 0.00% |
| Feb. 15, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 74,838,292 | 9999.99% | 0.07% |
| Jan. 30, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 366 | $27.25 | 44,181.0000 | 74,838,292 | 0.82% | 0.00% |
| Jan. 8, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1569 | $28.64 | 46,612.0000 | 74,838,292 | 3.26% | 0.00% |
| Jan. 9, 2024 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 2065 | $29.01 | 44,547.0000 | 74,838,292 | 4.43% | 0.00% |
| May 22, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 100 | $59.66 | 47,553.0000 | 73,729,284 | 0.21% | 0.00% |
| May 19, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 6403 | $58.96 | 49,566.0000 | 73,729,284 | 11.44% | 0.01% |
| May 22, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 1913 | $58.98 | 47,653.0000 | 73,729,284 | 3.86% | 0.00% |
| May 17, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 800 | $58.52 | 64,005.0000 | 73,729,284 | 1.23% | 0.00% |
| May 17, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 7248 | $58.50 | 56,757.0000 | 73,729,284 | 11.32% | 0.01% |
| May 18, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 788 | $58.71 | 55,969.0000 | 73,729,284 | 1.39% | 0.00% |
| April 18, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 732 | $52.04 | 64,805.0000 | 73,729,284 | 1.12% | 0.00% |
| Jan. 31, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 375 | $45.63 | 65,537.0000 | 71,728,634 | 0.57% | 0.00% |
| Jan. 24, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 359 | $47.45 | 65,912.0000 | 71,728,634 | 0.54% | 0.00% |
| Jan. 11, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 571 | $44.36 | 66,271.0000 | 71,728,634 | 0.85% | 0.00% |
| Jan. 10, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 663 | $42.93 | 66,842.0000 | 71,728,634 | 0.98% | 0.00% |
| Jan. 9, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | S | Common Stock | 858 | $41.66 | 67,505.0000 | 71,728,634 | 1.26% | 0.00% |
| Jan. 5, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | A | Common Stock | 18000 | $0.00 | 68,363.0000 | 71,728,634 | 35.74% | 0.03% |
| Jan. 5, 2023 | PTC THERAPEUTICS, INC. | $PTCT | Pauwels Eric | CHIEF BUSINESS OFFICER | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 71,728,634 | 9999.99% | 0.06% |